Group One Trading, L.P. Concert Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$4.34 - $5.84 $2,512 - $3,381	-579 Reduced 23.44%	1,891 $11,000
Q3 2022 Nov 09, 2022	SELL	$4.27 - $7.2 $24,467 - $41,256	-5,730 Reduced 69.88%	2,470 $17,000
Q2 2022 Aug 11, 2022	BUY	$2.8 - $6.36 $19,600 - $44,520	7,000 Added 583.33%	8,200 $35,000
Q1 2022 May 12, 2022	BUY	$2.73 - $3.94 $1,365 - $1,970	500 Added 71.43%	1,200 $4,000
Q4 2021 Feb 11, 2022	BUY	$2.69 - $4.22 $269 - $422	100 Added 16.67%	700 $2,000
Q3 2021 Nov 12, 2021	SELL	$3.17 - $4.15 $7,925 - $10,375	-2,500 Reduced 80.65%	600 $2,000
Q2 2021 Aug 10, 2021	BUY	$3.77 - $5.24 $11,687 - $16,244	3,100 New	3,100 $13,000
Q1 2021 May 12, 2021	SELL	$4.86 - $13.07 $432 - $1,163	-89 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.67 - $10.82 $771 - $962	89 New	89 $1,000
Q2 2020 Aug 13, 2020	SELL	$7.8 - $11.52 $8,782 - $12,971	-1,126 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$5.98 - $13.09 $53,449 - $116,998	-8,938 Reduced 88.81%	1,126 $10,000
Q4 2019 Feb 10, 2020	SELL	$5.71 - $9.22 $82,195 - $132,721	-14,395 Reduced 58.85%	10,064 $93,000
Q3 2019 Nov 12, 2019	BUY	$5.88 - $12.35 $94,585 - $198,662	16,086 Added 192.12%	24,459 $144,000
Q2 2019 Aug 09, 2019	BUY	$9.44 - $13.12 $42,961 - $59,709	4,551 Added 119.07%	8,373 $100,000
Q1 2019 May 13, 2019	BUY	$12.07 - $17.54 $34,061 - $49,497	2,822 Added 282.2%	3,822 $46,000
Q4 2018 Feb 06, 2019	BUY	$11.25 - $16.17 $4,500 - $6,468	400 Added 66.67%	1,000 $13,000
Q3 2018 Nov 08, 2018	SELL	$12.82 - $17.88 $3,397 - $4,738	-265 Reduced 30.64%	600 $9,000
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $14,557 - $18,735	865 New	865 $15,000
Q3 2017 Nov 15, 2017	SELL	$13.91 - $15.31 $397,784 - $437,820	-28,597 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	28,597	28,597 $399,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account